Discontinuation and nonpublication of pediatric otolaryngology clinical trials
Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common ped...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Johnson, Austin L. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study - Reyaz, Saima ELSEVIER, 2021, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:151 ; year:2021 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijporl.2021.110972 |
|---|
| Katalog-ID: |
ELV056000367 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV056000367 | ||
| 003 | DE-627 | ||
| 005 | 20230624224944.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220105s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijporl.2021.110972 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001609.pica |
| 035 | |a (DE-627)ELV056000367 | ||
| 035 | |a (ELSEVIER)S0165-5876(21)00365-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |a 004 |q VZ |
| 084 | |a 35.06 |2 bkl | ||
| 100 | 1 | |a Johnson, Austin L. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Discontinuation and nonpublication of pediatric otolaryngology clinical trials |
| 264 | 1 | |c 2021 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. | ||
| 650 | 7 | |a Discontinuation |2 Elsevier | |
| 650 | 7 | |a Clinical trials |2 Elsevier | |
| 650 | 7 | |a Publication |2 Elsevier | |
| 650 | 7 | |a Pediatric otolaryngology |2 Elsevier | |
| 650 | 7 | |a Randomized controlled trials |2 Elsevier | |
| 700 | 1 | |a Torgerson, Trevor |4 oth | |
| 700 | 1 | |a Adewumi, Mopileola Tomi |4 oth | |
| 700 | 1 | |a Kee, Micah |4 oth | |
| 700 | 1 | |a Farahani, Clay |4 oth | |
| 700 | 1 | |a Wehrmann, Daniel J. |4 oth | |
| 700 | 1 | |a Francis, Carrie L. |4 oth | |
| 700 | 1 | |a Vassar, Matt |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Reyaz, Saima ELSEVIER |t Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |d 2021 |g Amsterdam [u.a.] |w (DE-627)ELV006862241 |
| 773 | 1 | 8 | |g volume:151 |g year:2021 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijporl.2021.110972 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.06 |j Computeranwendungen |x Chemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 151 |j 2021 |h 0 | ||
| author_variant |
a l j al alj |
|---|---|
| matchkey_str |
johnsonaustinltorgersontrevoradewumimopi:2021----:icniutoadopbiainfeitiooay |
| hierarchy_sort_str |
2021 |
| bklnumber |
35.06 |
| publishDate |
2021 |
| allfields |
10.1016/j.ijporl.2021.110972 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001609.pica (DE-627)ELV056000367 (ELSEVIER)S0165-5876(21)00365-7 DE-627 ger DE-627 rakwb eng 540 004 VZ 35.06 bkl Johnson, Austin L. verfasserin aut Discontinuation and nonpublication of pediatric otolaryngology clinical trials 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials Elsevier Torgerson, Trevor oth Adewumi, Mopileola Tomi oth Kee, Micah oth Farahani, Clay oth Wehrmann, Daniel J. oth Francis, Carrie L. oth Vassar, Matt oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:151 year:2021 pages:0 https://doi.org/10.1016/j.ijporl.2021.110972 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 151 2021 0 |
| spelling |
10.1016/j.ijporl.2021.110972 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001609.pica (DE-627)ELV056000367 (ELSEVIER)S0165-5876(21)00365-7 DE-627 ger DE-627 rakwb eng 540 004 VZ 35.06 bkl Johnson, Austin L. verfasserin aut Discontinuation and nonpublication of pediatric otolaryngology clinical trials 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials Elsevier Torgerson, Trevor oth Adewumi, Mopileola Tomi oth Kee, Micah oth Farahani, Clay oth Wehrmann, Daniel J. oth Francis, Carrie L. oth Vassar, Matt oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:151 year:2021 pages:0 https://doi.org/10.1016/j.ijporl.2021.110972 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 151 2021 0 |
| allfields_unstemmed |
10.1016/j.ijporl.2021.110972 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001609.pica (DE-627)ELV056000367 (ELSEVIER)S0165-5876(21)00365-7 DE-627 ger DE-627 rakwb eng 540 004 VZ 35.06 bkl Johnson, Austin L. verfasserin aut Discontinuation and nonpublication of pediatric otolaryngology clinical trials 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials Elsevier Torgerson, Trevor oth Adewumi, Mopileola Tomi oth Kee, Micah oth Farahani, Clay oth Wehrmann, Daniel J. oth Francis, Carrie L. oth Vassar, Matt oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:151 year:2021 pages:0 https://doi.org/10.1016/j.ijporl.2021.110972 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 151 2021 0 |
| allfieldsGer |
10.1016/j.ijporl.2021.110972 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001609.pica (DE-627)ELV056000367 (ELSEVIER)S0165-5876(21)00365-7 DE-627 ger DE-627 rakwb eng 540 004 VZ 35.06 bkl Johnson, Austin L. verfasserin aut Discontinuation and nonpublication of pediatric otolaryngology clinical trials 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials Elsevier Torgerson, Trevor oth Adewumi, Mopileola Tomi oth Kee, Micah oth Farahani, Clay oth Wehrmann, Daniel J. oth Francis, Carrie L. oth Vassar, Matt oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:151 year:2021 pages:0 https://doi.org/10.1016/j.ijporl.2021.110972 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 151 2021 0 |
| allfieldsSound |
10.1016/j.ijporl.2021.110972 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001609.pica (DE-627)ELV056000367 (ELSEVIER)S0165-5876(21)00365-7 DE-627 ger DE-627 rakwb eng 540 004 VZ 35.06 bkl Johnson, Austin L. verfasserin aut Discontinuation and nonpublication of pediatric otolaryngology clinical trials 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials Elsevier Torgerson, Trevor oth Adewumi, Mopileola Tomi oth Kee, Micah oth Farahani, Clay oth Wehrmann, Daniel J. oth Francis, Carrie L. oth Vassar, Matt oth Enthalten in Elsevier Science Reyaz, Saima ELSEVIER Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study 2021 Amsterdam [u.a.] (DE-627)ELV006862241 volume:151 year:2021 pages:0 https://doi.org/10.1016/j.ijporl.2021.110972 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.06 Computeranwendungen Chemie VZ AR 151 2021 0 |
| language |
English |
| source |
Enthalten in Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study Amsterdam [u.a.] volume:151 year:2021 pages:0 |
| sourceStr |
Enthalten in Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study Amsterdam [u.a.] volume:151 year:2021 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Computeranwendungen |
| institution |
findex.gbv.de |
| topic_facet |
Discontinuation Clinical trials Publication Pediatric otolaryngology Randomized controlled trials |
| dewey-raw |
540 |
| isfreeaccess_bool |
false |
| container_title |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| authorswithroles_txt_mv |
Johnson, Austin L. @@aut@@ Torgerson, Trevor @@oth@@ Adewumi, Mopileola Tomi @@oth@@ Kee, Micah @@oth@@ Farahani, Clay @@oth@@ Wehrmann, Daniel J. @@oth@@ Francis, Carrie L. @@oth@@ Vassar, Matt @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV006862241 |
| dewey-sort |
3540 |
| id |
ELV056000367 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056000367</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624224944.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijporl.2021.110972</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001609.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056000367</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-5876(21)00365-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">004</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.06</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Johnson, Austin L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Discontinuation and nonpublication of pediatric otolaryngology clinical trials</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Discontinuation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Publication</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pediatric otolaryngology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Randomized controlled trials</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Torgerson, Trevor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Adewumi, Mopileola Tomi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kee, Micah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farahani, Clay</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wehrmann, Daniel J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Francis, Carrie L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vassar, Matt</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Reyaz, Saima ELSEVIER</subfield><subfield code="t">Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV006862241</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:151</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijporl.2021.110972</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.06</subfield><subfield code="j">Computeranwendungen</subfield><subfield code="x">Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">151</subfield><subfield code="j">2021</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Johnson, Austin L. |
| spellingShingle |
Johnson, Austin L. ddc 540 bkl 35.06 Elsevier Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials Discontinuation and nonpublication of pediatric otolaryngology clinical trials |
| authorStr |
Johnson, Austin L. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV006862241 |
| format |
electronic Article |
| dewey-ones |
540 - Chemistry & allied sciences 004 - Data processing & computer science |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
540 004 VZ 35.06 bkl Discontinuation and nonpublication of pediatric otolaryngology clinical trials Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials Elsevier |
| topic |
ddc 540 bkl 35.06 Elsevier Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials |
| topic_unstemmed |
ddc 540 bkl 35.06 Elsevier Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials |
| topic_browse |
ddc 540 bkl 35.06 Elsevier Discontinuation Elsevier Clinical trials Elsevier Publication Elsevier Pediatric otolaryngology Elsevier Randomized controlled trials |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t t tt m t a mt mta m k mk c f cf d j w dj djw c l f cl clf m v mv |
| hierarchy_parent_title |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| hierarchy_parent_id |
ELV006862241 |
| dewey-tens |
540 - Chemistry 000 - Computer science, knowledge & systems |
| hierarchy_top_title |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV006862241 |
| title |
Discontinuation and nonpublication of pediatric otolaryngology clinical trials |
| ctrlnum |
(DE-627)ELV056000367 (ELSEVIER)S0165-5876(21)00365-7 |
| title_full |
Discontinuation and nonpublication of pediatric otolaryngology clinical trials |
| author_sort |
Johnson, Austin L. |
| journal |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| journalStr |
Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science 000 - Computer science, information & general works |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Johnson, Austin L. |
| container_volume |
151 |
| class |
540 004 VZ 35.06 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Johnson, Austin L. |
| doi_str_mv |
10.1016/j.ijporl.2021.110972 |
| dewey-full |
540 004 |
| title_sort |
discontinuation and nonpublication of pediatric otolaryngology clinical trials |
| title_auth |
Discontinuation and nonpublication of pediatric otolaryngology clinical trials |
| abstract |
Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. |
| abstractGer |
Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. |
| abstract_unstemmed |
Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Discontinuation and nonpublication of pediatric otolaryngology clinical trials |
| url |
https://doi.org/10.1016/j.ijporl.2021.110972 |
| remote_bool |
true |
| author2 |
Torgerson, Trevor Adewumi, Mopileola Tomi Kee, Micah Farahani, Clay Wehrmann, Daniel J. Francis, Carrie L. Vassar, Matt |
| author2Str |
Torgerson, Trevor Adewumi, Mopileola Tomi Kee, Micah Farahani, Clay Wehrmann, Daniel J. Francis, Carrie L. Vassar, Matt |
| ppnlink |
ELV006862241 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijporl.2021.110972 |
| up_date |
2024-07-06T19:08:22.927Z |
| _version_ |
1803857850980630528 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056000367</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624224944.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijporl.2021.110972</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001609.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056000367</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-5876(21)00365-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">004</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.06</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Johnson, Austin L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Discontinuation and nonpublication of pediatric otolaryngology clinical trials</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Randomized controlled trial (RCT) discontinuation and nonpublication are potential mechanisms of waste in resources and lead to decreased advancement of medical science and compromised ethical issues in all specialties. However, the prevalence of discontinued or unpublished RCTs regarding common pediatric otolaryngology disorders and interventions remains unclear.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Discontinuation</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Publication</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pediatric otolaryngology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Randomized controlled trials</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Torgerson, Trevor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Adewumi, Mopileola Tomi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kee, Micah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farahani, Clay</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wehrmann, Daniel J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Francis, Carrie L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vassar, Matt</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Reyaz, Saima ELSEVIER</subfield><subfield code="t">Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV006862241</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:151</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijporl.2021.110972</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.06</subfield><subfield code="j">Computeranwendungen</subfield><subfield code="x">Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">151</subfield><subfield code="j">2021</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.400571 |